Agent consensus
OVERWEIGHT
Multi-agent note output
GM
Equity research — GM (as of 2026-08-07)
Updated Aug 7, 2026
Coverage
GM
Freshness
3 days ago
Market chart
Price context alongside the research narrative.
How the call aged
A simple read on whether this desk view matched what happened in the market over the next 5 trading days, with recent price context from the as-of date.
Desk view: OVERWEIGHTNot gradedVs peers: Weaker than mostAwaiting market data
Price move
—
2026-08-07 → awaiting data
5-day trend
-1.44%
20-day trend
+12.50%
Recent volatility
+35.33%
vs SPY (5d): -4.95%
Close 87.58 → —
Desk briefing
GM is a 12-month Overweight. At the latest close of $86.94, the stock trades at roughly 5.9x forward earnings using the vendor forward EPS of $14.71 — a multiple that still embeds meaningful skepticism about GM’s ability to sustain curre...
Full research note
Presentation-ready note with specialist analyst agents, bull and bear agent debate, trader agent synthesis, risk challenge, and portfolio sign-off.
WebserviceX.NET Research Desk
GM Equity Research Note
Summary
GM is a 12-month Overweight. At the latest close of $86.94, the stock trades at roughly 5.9x forward earnings using the vendor forward EPS of $14.71 — a multiple that still embeds meaningful skepticism about GM’s ability to sustain curre...
Bias
OVERWEIGHT
Horizon
Long-term
Key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
Catalyst watch
Implement the 12-month Overweight via scale-in buying on weakness rather than chasing strength around $90–$91.85.